PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This Phase 1 trial will evaluate the safety and tolerability of PSA-Activated PSA-PAH1 in
subjects who have shown biochemical failure and have either completed at least one primary
radiation therapy for prostate cancer and have evidence of recurrent local prostate cancer
without metastases.